Itau Unibanco Holding S.A.’s Sarepta Therapeutics SRPT Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-95	Closed	-$15K	–	420
2024 Q2	$15K	Buy	+95	New	+$12.2K	﹤0.01%	254
2024 Q1	–	Sell	-169	Closed	-$16.3K	–	329
2023 Q4	$16.3K	Sell	169 -26	-13%	-$2.49K	﹤0.01%	290
2023 Q3	$23.6K	Hold	195	–	–	﹤0.01%	353
2023 Q2	$22.3K	Sell	195 -37	-16%	-$4.77K	﹤0.01%	396
2023 Q1	$32K	Hold	232	–	–	﹤0.01%	366
2022 Q4	$30.1K	Sell	232 -32	-12%	-$3.71K	﹤0.01%	366
2022 Q3	$29K	Hold	264	–	–	﹤0.01%	417
2022 Q2	$20K	Sell	264 -19	-7%	-$1.4K	﹤0.01%	393
2022 Q1	$22K	Hold	283	–	–	﹤0.01%	377
2021 Q4	$26K	Buy	283 +92	+48%	+$7.87K	﹤0.01%	353
2021 Q3	$18K	Buy	191 +5	+3%	+$385	﹤0.01%	343
2021 Q2	$14K	Buy	+186	New	+$14.1K	﹤0.01%	327

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Itau Unibanco Holding S.A.'s SRPT Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of Sarepta Therapeutics (SRPT) in Q3 2024, closing a stake of 95 shares — an estimated $15K sold.

Itau Unibanco Holding S.A. first reported a position in SRPT in Q2 2021 and held it in 12 quarters. The position peaked at $32K in Q1 2023. 457 funds tracked by Wall St. Rank hold SRPT as of Q3 2024.

Itau Unibanco Holding S.A. reported no remaining Sarepta Therapeutics position as of Q3 2024 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 95 Sarepta Therapeutics shares in Q3 2024, an estimated $15K.
Itau Unibanco Holding S.A. first reported a position in Sarepta Therapeutics in Q2 2021 and held it in 12 quarters.
Itau Unibanco Holding S.A.'s Sarepta Therapeutics position peaked at $32K in Q1 2023.
457 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.